The invention provides a method for preparing and synthesizing a
statin medicinal intermediate, namely, an (R)-3-hydroxy-
glutaric acid ethyl ester or a hydroxy substituted derivative of the (R)-3-hydroxy-
glutaric acid ethyl ester with high optical activity by performing chiral separation on a racemic 4-cyano-group-3-hydroxy
butyric acid ethyl ester or a hydroxy substituted derivative of the 4-cyano-group-3-hydroxy
butyric acid ethyl ester and a strain. The method comprises the following steps: performing a
conversion reaction in a
reaction system in which a compound shown in a formula (11) is used as a substrate and an
enzyme obtained by fermenting and culturing
rhodococcus erythropolis CCTCC No:M 209244 or CCTCC No:M 209194 is used as a catalyst at the temperature of between 10 and 50 DEG C; and after the reaction, separating and purifying reaction liquid to obtain the compound shown in formula (I). The method realizes obtaining the (R)-3-hydroxy-
glutaric acid ethyl ester or the hydroxy substituted derivative of the (R)-3-hydroxy-glutaric acid ethyl ester with high optical activity by catalyzing and hydrolyzing the racemic 4-cyano-group-3-hydroxy
butyric acid ethyl ester or the hydroxy substituted derivative of the 4-cyano-group-3-hydroxy
butyric acid ethyl ester in one step under the condition of not hydrolyzing an ester group in the substrate or producing any byproduct, and overcomes the defects of more byproducts, low target product yield, low optical purity and the like brought by a conventional synthetic method in a hydrolyzing process, such as a chemical method.